Cipla & Pharma Stocks Surge on US Drug Price News

  Published 1 year ago

Cipla shares are rising, mirroring gains in the pharma sector, fueled by reports the US has exempted generic drugs from planned price cuts. This news from Reuters is boosting investor confidence.

  • Cipla stock is trading higher today.
  • US exempts generics from price cuts.
  • Positive outlook for pharma companies.

You might like these

RBI Eases Credit Norms for Infra Bonds

India's CHIMERA 200: Defense Tech Breakthrough

ITI Receives ₹25 Crore from C-DOT Land Deal

Capgemini Stock Dives Over AI BPO Concerns

Tanla Platforms Announces CPaaS Messaging Security Leadership

Jindal Stainless Q1 Profit Up Amid Trade Woes

NBCC Bags Major Contracts in India

News that matters the most ⚡